NIDA Clinical Trials Network (CTN), New York Node
Founded in 2000, the NIDA Clinical Trials Network (CTN) comprises sixteen nodes, a Clinical Coordinating Center, and a Data and Statistics Center, forming a national infrastructure for conducting rigorous multi-site trials of treatments for substance use disorders (SUD) that have the potential to improve practice across the continuum of care.
The New York Node (NYN) supports NIDA’s objectives to improve addiction care nationwide through research conducted by its Clinical Trials Network (CTN). Situated in the largest and most diverse U.S. metropolitan area, the NYN contributes expertise in virtually all key CTN priorities including: capacity to conceptualize, design, lead, and support large trials; collaborations with health systems and community-based addiction treatment and harm reduction providers; and robust experience in developing and testing new therapies and delivery strategies, implementation science, community-engaged research, and using existing data sources to explore new research questions.
